近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Puspitasari, H., Costa, D., Aslani, P., Krass, I. (2016). An explanatory model of community pharmacists’ support in the secondary prevention of cardiovascular disease. Research in Social and Administrative Pharmacy, 12(1), 104-118. [More Information]
Ahmed, R., McCaffery, K., Aslani, P. (2016). Development and validation of a question prompt list for parents of children with attention-deficit/hyperactivity disorder: A Delphi study. Health Expectations, 19(2), 234-252. [More Information]
Tong, V., Raynor, D., Blalock, S., Aslani, P. (2016). Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leaflets. Health Expectations, 19(3), 543-556. [More Information]
Tong, V., Raynor, D., Aslani, P. (2016). It's all there in black and white' - or is it? Consumer perspectives on the proposed Australian Medicine Information Box over-the-counter label format. Health Expectations, 19(4), 948-961. [More Information]
Rathbone, A., Mansoor, S., Krass, I., Hamrosi, K., Aslani, P. (2016). Qualitative study to conceptualise a model of interprofessional collaboration between pharmacists and general practitioners to support patients' adherence to medication. BMJ Open, 6(3), 1-9. [More Information]
Ahmed, R., McCaffery, K., Silove, N., Butow, P., Clarke, S., Kohn, M., Aslani, P. (2016). The evaluation of a question prompt list for attention-deficit/hyperactivity disorder in pediatric care: A pilot study. Research in Social and Administrative Pharmacy, In Press. [More Information]
Sapkota, S., Brien, J., Greenfield, J., Aslani, P. (2015). A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes - Impact on adherence. PloS One, 10(2), 1-17. [More Information]
Sapkota, S., Brien, J., Greenfield, J., Aslani, P. (2015). A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes-Components of Interventions. PloS One, 10(6), 1-30. [More Information]
Puspitasari, H., Aslani, P., Krass, I. (2015). Challenges in the management of chronic noncommunicable diseases by indonesian community pharmacists | Retos en el manejo de enfermedades crónicas no declarables por los farmacéuticos comunitarios indonesios. Pharmacy Practice, 13(3), 1-12. [More Information]
Tong, V., Raynor, D., Blalock, S., Aslani, P. (2015). Consumer interpretation of ramipril and clopidogrel medication risk information - Implications for risk communication strategies. Patient Preference and Adherence, 9, 983-988. [More Information]
Hogan, A., Bonney, M., Brien, J., Karamy, R., Aslani, P. (2015). Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study. International Journal of Clinical Pharmacy, 37(1), 86-93. [More Information]
Mansoor, S., Krass, I., Costa, D., Aslani, P. (2015). Factors influencing the provision of adherence support by community pharmacists: A structural equation modeling approach. Research in Social and Administrative Pharmacy, 11(6), 769-783. [More Information]
Benetoli, A., Chen, T., Spagnardi, S., Beer, T., Aslani, P. (2015). Provision of a Medicines Information Service to Consumers on Facebook: An Australian Case Study. Journal of Medical Internet Research, 17(11), 1-10. [More Information]
Puspitasari, H., Aslani, P., Krass, I. (2015). The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease. International Journal of Clinical Pharmacy, 37(5), 834-843. [More Information]
Benetoli, A., Chen, T., Aslani, P. (2015). The use of social media in pharmacy practice and education. Research in Social and Administrative Pharmacy, 11(1), 1-46. [More Information]
Aslani, P., Schneider, M. (2014). Adherence: the journey of medication taking, are we there yet? International Journal of Clinical Pharmacy, 36(1), 1-3. [More Information]
Lehmann, A., Aslani, P., Ahmed, R., Celio, J., Gauchet, A., Bedouch, P., Bugnon, O., Allenet, B., Schneider, M. (2014). Assessing medication adherence: options to consider. International Journal of Clinical Pharmacy, 36(1), 55-69. [More Information]
Hamrosi, K., Aslani, P., Raynor, D. (2014). Beyond needs and expectations: identifying the barriers and facilitators to written medicine information provision and use in Australia. Health Expectations, 17(2), 220-231. [More Information]
Puspitasari, H., Aslani, P., Krass, I. (2014). Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists. PloS One, 9(11), 1-10. [More Information]
Liekens, S., Aslani, P., Chen, T., Roter, D., Larson, S., Smits, T., Laekeman, G., Foulon, V. (2014). Content coding of pharmacist-patient interactions in medication counseling in mental health. Patient Education and Counseling. [More Information]